Hubert Fleury
Impact in
- Reproductive Medicine top 5%
- Ovarian cancer diagnosis and treatment
-
- PARP inhibition in cancer therapy
Papers in
-
- Ovarian cancer diagnosis and treatment 4
- Oncology 4
- PARP inhibition in cancer therapy 4
- Co-authors
- Anne‐Marie Mes‐Masson (10 shared papers)Eurı́dice Carmona (7 shared papers)Diane Michele Provencher (7 shared papers)Laudine Communal (2 shared papers)Françis Rodier (1 shared paper)Nicolas Malaquin (1 shared paper)Aurélie Martinez (1 shared paper)Marc‐Alexandre Olivier (1 shared paper)
- Journals
- Oncotarget (2 papers)BMC Medicine (1 paper)Scientific Reports (1 paper)Nature Communications (1 paper)Integrative Biology (1 paper)
- Partner nations
- CanadaUnited KingdomJapan
In The Last Decade
Hubert Fleury
15 papers receiving 681 citations
Peers
Comparison fields: 5 of 31
- Reproductive Medicine 152
- Oncology 103
- Physiology 14
- Physiology 99
- Cancer Research 30
Countries citing papers authored by Hubert Fleury
This map shows the geographic impact of Hubert Fleury's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hubert Fleury with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hubert Fleury more than expected).
Fields of papers citing papers by Hubert Fleury
This network shows the impact of papers produced by Hubert Fleury. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hubert Fleury. The network helps show where Hubert Fleury may publish in the future.
Co-authors
The 25 scholars most cited alongside Hubert Fleury, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 214 | |
| 2 | 2019 | 188 | |
| 3 | 2016 | 42 | |
| 4 | 2021 | 36 | |
| 5 | 2023 | 32 | |
| 6 | 2015 | 28 | |
| 7 | 2016 | 28 | |
| 8 | 2020 | 21 | |
| 9 | 2022 | 18 | |
| 10 | 2015 | 16 | |
| 11 | 2023 | 15 | |
| 12 | 2016 | 14 | |
| 13 | 2021 | 14 | |
| 14 | 2021 | 11 | |
| 15 | 2019 | 6 |
About Hubert Fleury
Hubert Fleury is a scholar working on Reproductive Medicine, Oncology, Physiology, Cell Biology and Molecular Biology, having authored 15 papers that have together received 683 indexed citations. Recurring topics across this work include PARP inhibition in cancer therapy (4 papers), Ovarian cancer diagnosis and treatment (4 papers), DNA Repair Mechanisms (2 papers), Adenosine and Purinergic Signaling (1 paper), Microtubule and mitosis dynamics (1 paper) and BRCA gene mutations in cancer (1 paper). The work is most often cited by research in Reproductive Medicine (152 citations), Oncology (103 citations), Physiology (14 citations), Physiology (99 citations) and Cancer Research (30 citations). Hubert Fleury has collaborated with scholars based in Canada, United Kingdom and Japan. Frequent co-authors include Anne‐Marie Mes‐Masson, Eurı́dice Carmona, Diane Michele Provencher, Laudine Communal, Françis Rodier, Nicolas Malaquin, Aurélie Martinez, Marc‐Alexandre Olivier, Patricia N. Tonin and Jean‐Yves Masson. Their work appears in journals such as Oncotarget, BMC Medicine, Scientific Reports, Nature Communications and Integrative Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.